FDA Adverse Event Death Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 2950388 · Received February 8, 2013

Report

Report Number
2024168-2013-00740
Event Type
Death
Date Received
February 8, 2013
Date of Event
June 15, 2009
Report Date
January 16, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIM
PMA / PMN Number
P040038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. (B)(4): ARTICLE: STAGED CAROTID ARTERY STENTING AND CORONARY ARTERY BYPASS SURGERY VERSUS ISOLATED CORONARY ARTERY BYPASS SURGERY IN CONCOMITANT CORONARY AND CAROTID DISEASE. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECT OF DEATH IS A KNOWN OBSERVED AND POTENTIAL ADVERSE EVENT AS LISTED IN THE XACT CAROTID STENT SYSTEM INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING. (B)(4).

Description of Event or Problem · 1

THE FOLLOWING EVENTS WERE NOTED THROUGH A PERIODIC ARTICLE REVIEW. A (B)(6) STUDY, CONDUCTED BETWEEN MARCH 2007 AND FEBRUARY 2010, WAS PERFORMED IN 62 PATIENTS IN WHOM CAROTID ARTERY STENTING AND CORONARY ARTERY BYPASS GRAFT SURGERY WAS PERFORMED. ALL PATIENTS HAD SIGNIFICANT CAROTID ARTERY STENOSIS (>70%) AND WERE CANDIDATES FOR CORONARY ARTERY BYPASS GRAFT. CAROTID ARTERY STENTING WAS TECHNICALLY SUCCESSFUL IN ALL 62 PATIENTS. THREE DEATHS OCCURRED, 2 OF NEUROLOGICAL CAUSES AND 1 FROM CARDIAC CAUSES. OF THE 62 PATIENTS, 5 XACT STENTS AND 1 ACCULINK STENT WERE IMPLANTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
54890 XACT CAROTID STENT SYSTEM CAROTID STENT SYSTEM NIM AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 Death EMBOLIC PROTECTION: EMBOSHIELDSTENT: ACCULINK